Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baidianfeng Capsules (白癜风胶囊) is a traditional Chinese medicine (TCM) product manufactured by Tianjin Hong Ren Tang Pharmaceutical, specifically indicated for the treatment of vitiligo. The formulation is based on TCM principles of tonifying the liver and kidney, nourishing the blood, and dispelling "wind" to treat skin depigmentation. It contains a complex mixture of herbal ingredients, including *Psoralea corylifolia* (Bu Gu Zhi), which is known to contain psoralens that sensitize the skin to ultraviolet light and stimulate melanocytes. Other components like *Astragalus* and *Salvia miltiorrhiza* are intended to improve microcirculation and modulate immune function. The drug is administered orally and has been approved for marketing in China by the National Medical Products Administration (NMPA).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baidianfeng Capsules.